Sven Kili

Sven Kili currently serves as the Chief Development Officer at CCRM and is a Member of the Board. Additionally, Sven is the Investment Advisor at Saisei Ventures, Principal at SVEN KILI CONSULTING LTD, Steering Committee Chair at UCL, Chair of the Cell & Gene Therapy Advisory Committee at BioIndustry Association, Member of The Scientific Advisory Board at LGC Group, and was previously the Chief Executive Officer at Antion Biosciences SA. Sven also served as a Member of the Board at Xintela AB, Member of the Executive Board at Standards Coordinating Body (SCB), and Vice President and Head of Cell & Gene Therapy Development at GSK in the past. Sven holds a degree in Surgery from the Royal College of Surgeons of England and a degree in Medicine & Surgery from Stellenbosch University.